Oxford Biomedica Plc (OXBL)

564.50p
   
  • Change Today:
    -0.065p
  • 52 Week High: 574.00p
  • 52 Week Low: 235.50p
  • Currency: UK Pounds
  • Volume: 4,906

OXBL Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

Key Personnel

CEO: Frank Mathias
CFO: Lucinda (Lucy) Crabtree
Chairman: Roch Doliveux
Independent Non-Executive Director: Heather Preston
Independent Non-Executive Director: Namrata P Patel
Senior Independent Director: Dame Kay Davies
Non-Executive Dir: Laurence Espinasse, Colin Bond , Peter Soelkner, Robert Ghenchev

Contact Details

Address: Windrush Court, Transport Way, Oxford, United Kingdom, OX4 6LT
Phone: +44 (0) 1865 783 000
Fax: +44 (0) 1865 783 001
Website: http://www.oxb.com/

Listings

Overseas Listings: LSE:OXB
ISIN: GB0006648157

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

 

OXBL Market Data

Currency UK Pounds
Share Price 564.50p
Change Today -0.065p
% Change -1.14 %
52 Week High 574.00p
52 Week Low 235.50p
Volume 4,906

Trades for 29-Aug-2025

Time Volume / Share Price
16:28 287 @ 567.00p
16:26 193 @ 566.00p
16:26 61 @ 566.00p
16:24 30 @ 568.00p
16:22 259 @ 567.00p

OXBL Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page